Siirry suoraan sisältöön
Botanical Drug Products
Tallenna

Botanical Drug Products

sidottu, 2018
englanti

Botanicals, which have been part of human food and medicine for thousands of years, are perceived as being safer than synthetic pharmaceuticals. The global botanical drug market was expected to reach $26.6 billion by 2017. In terms of FDA regulations, botanical drugs are no different from non-botanical products, having to meet the safety and effectiveness standards of a new drug in accordance. This book comprises a complete start-to-end process from drug-idea conception, to drug development process.

Key Features:

  • Provides a complete compendium for botanical drug products
  • Describes what BDP is and how it differs from Pharma, Biopharma, and Nutraceuticals
  • Compiles all critical regulatory steps in a variety of countries
  • Discusses clinical trial management for BDP development and how it differs from conventional chemical-based drugs and biopharmaceutics
    • Alaotsikko
    Recent Developments and Market Trends
    ISBN
    9781498740050
    Kieli
    englanti
    Paino
    566 grammaa
    Julkaisupäivä
    29.11.2018
    Sivumäärä
    274